SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020615
Filing Date
2024-06-18
Accepted
2024-06-18 13:13:44
Documents
16
Period of Report
2024-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240618_8k.htm   iXBRL 8-K 29684
2 EXHIBIT 99.1 ex_689956.htm EX-99.1 18360
7 logo01.jpg GRAPHIC 5600
  Complete submission text file 0001437749-24-020615.txt   218193

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20240612.xsd EX-101.SCH 3851
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240612_def.xml EX-101.DEF 14131
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240612_lab.xml EX-101.LAB 18605
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240612_pre.xml EX-101.PRE 14218
19 EXTRACTED XBRL INSTANCE DOCUMENT govx20240618_8k_htm.xml XML 4764
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241050873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)